Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05537883 · ClinicalTrials.gov registry record · Phase 1
Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients
A Phase 1 study of Bariatric Surgery Candidate and Morbid Obesity, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05537883 is a Phase 1 study of Bariatric Surgery Candidate and Morbid Obesity that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 72 participants, below the 111-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05537883, a Phase 1 study of Bariatric Surgery Candidate and Morbid Obesity, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
To investigate if laparoscopic Transversus Abdominis Plane (TAP) block using plain bupivacaine is equivalent to using liposomal bupivacaine in patients undergoing metabolic and bariatric surgery. The study will see if the plain bupivacaine group will be equivalent in terms of length of stay, Morphine Milligram Equivalents, Pain scores and patient satisfaction, but cost less.
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
- DRUG Bupivacaine Injection
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-11-29 |
| Est. Completion | 2023-12-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05537883
The ClinicalTrials.gov registry entry for NCT05537883 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (35% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT05537883 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05537883 about?
NCT05537883 is a clinical study titled "Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients". To investigate if laparoscopic Transversus Abdominis Plane (TAP) block using plain bupivacaine is equivalent to using liposomal bupivacaine in patients undergoing metabolic and bariatric surgery. The study will see if the plain bupivacaine group will be equivalent in terms of length of stay, Morphin...
What is the current status of trial NCT05537883?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2022-11-29. Estimated completion is 2023-12-07.
What conditions does trial NCT05537883 study?
This clinical trial studies the following conditions: Bariatric Surgery Candidate, Morbid Obesity.
What interventions are being tested in trial NCT05537883?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Bupivacaine Injection (DRUG).
Who is sponsoring clinical trial NCT05537883?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05537883 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery Candidate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
COMPLETED · Phase 1
-
Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients
COMPLETED · Phase 1
-
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
RECRUITING · NA
-
ViSiGi LUX Bariatric Sizing and Calibration System
RECRUITING
-
GI Oxalate Absorption
RECRUITING · NA
-
CV Imaging of Metabolic Interventions
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.